---
layout: default
title: Sodium Chloride
parent: 僅模型預測 (L5)
nav_order: 910
evidence_level: L5
indication_count: 10
---

# Sodium Chloride
{: .fs-9 }

證據等級: **L5** | 預測適應症: **10** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Sodium Chloride: From Undocumented Original Use to Breast Fibrocystic Disease

## One-Sentence Summary

Sodium chloride (NaCl, DrugBank DB09153) has no documented original indication or market registration in this evidence pack — it is currently **not marketed** in Singapore. The TxGNN model's top-ranked prediction is **Breast Fibrocystic Disease**, but the supporting evidence pack itself flags this link as likely **knowledge-graph noise** rather than a genuine pharmacological signal, with **1 non-treatment clinical trial** and **7 basic-research publications** — none demonstrating therapeutic efficacy.

---

## Quick Overview

| Item | Content |
|------|------|
| Original Indication | Not documented (no licenses or filed indication text in evidence pack) |
| Predicted New Indication | Breast Fibrocystic Disease |
| TxGNN Prediction Score | 96.79% |
| Evidence Level | L5 (model prediction only, no supportive treatment studies) |
| Singapore Market Status | ✗ Not Marketed |
| Number of Registrations | 0 |
| Recommended Decision | Hold |

---

## Why is This Prediction Reasonable?

Currently, detailed mechanism of action data is not available for sodium chloride in this evidence pack. Based on known pharmacology, NaCl is an inert electrolyte with no intrinsic pharmacodynamic activity of its own — it functions physiologically as an isotonic/physiological solution used for hydration, irrigation, and as a diluent, rather than acting on a specific disease target.

For the top-ranked candidate, **Breast Fibrocystic Disease**, the evidence pack explicitly assesses this link as a **knowledge-graph artifact**: the single associated clinical trial (NCT02887937) is a diagnostic contrast-enhanced ultrasound imaging study with no NaCl intervention arm, and the literature consists of basic biochemistry research characterizing sodium/potassium and chloride concentrations in breast cyst fluid — not therapeutic studies. No causal or mechanistic pathway connects NaCl administration to resolution of fibrocystic breast disease.

By contrast, two lower-ranked candidates in this pack — **vulvovaginitis** and **vulvitis** (ranks 2–3, TxGNN scores ~96.7% and ~96.3%) — have a more plausible, if weak, mechanistic rationale: saline vaginal irrigation as a non-specific physical/osmotic adjunct (dilution of irritants/pathogens, mucosal moisture support) rather than a pharmacological antimicrobial effect. One directly relevant comparative study (PMID 22301569) examined saline irrigation as an adjunct to antibiotic therapy in infectious vaginitis. These were rated L3 ("Research Question" stage) versus L5 ("Hold") for the top-ranked candidate.

---

## Clinical Trial Evidence

*(For the top-ranked predicted indication: Breast Fibrocystic Disease)*

| Trial Number | Phase | Status | Enrollment | Key Findings |
|---------|------|------|------|---------|
| [NCT02887937](https://clinicaltrials.gov/study/NCT02887937) | N/A | Completed | 135 | Diagnostic imaging study evaluating contrast-enhanced ultrasound to determine whether biopsy is necessary for cystic breast masses; no NaCl treatment arm — classified as low relevance (Grade C) |

---

## Literature Evidence

*(For the top-ranked predicted indication: Breast Fibrocystic Disease)*

| PMID | Year | Type | Journal | Key Findings |
|------|-----|------|------|---------|
| [9375824](https://pubmed.ncbi.nlm.nih.gov/9375824/) | 1997 | Comparative Study | Nephron | Compared amino acid and electrolyte composition of breast cyst fluid vs. polycystic kidney disease cyst fluid |
| [2140797](https://pubmed.ncbi.nlm.nih.gov/2140797/) | 1990 | Basic Research | Eur J Surg Oncol | Classified breast cysts by intracystic Na⁺/K⁺ ratio, chloride, glucose, and pH — descriptive biochemistry, not treatment |
| [2015669](https://pubmed.ncbi.nlm.nih.gov/2015669/) | 1991 | Basic Research | Clinical Chemistry | Identified GCDFP-70 protein in cyst fluid as albumin, used for cyst subtype classification |
| [10797312](https://pubmed.ncbi.nlm.nih.gov/10797312/) | 2000 | Basic Research | J Cell Physiol | Studied intracellular pH regulation in normal vs. malignant breast cell lines; unrelated to NaCl therapy |
| [3369685](https://pubmed.ncbi.nlm.nih.gov/3369685/) | 1988 | Basic Research | Analytical Biochemistry | Collagen fractionation technique using alkaline potassium chloride, not sodium chloride treatment |
| [3232934](https://pubmed.ncbi.nlm.nih.gov/3232934/) | 1988 | Case Series | Annals of Plastic Surgery | 9-year experience with saline-inflatable breast implant reconstruction (device, not therapeutic NaCl use) |
| [23073330](https://pubmed.ncbi.nlm.nih.gov/23073330/) | 2012 | Case Report | Am J Surg Pathol | Rare lymphoma case arising near a saline breast implant — adverse event report, not efficacy evidence |

---

## Singapore Market Information

No registered products found. Sodium chloride has **0 licenses** on file and is currently **not marketed** in Singapore under this evidence pack.

---

## Safety Considerations

Please refer to the package insert for safety information. No key warnings, contraindications, or drug interaction data were available in this evidence pack.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The top-ranked prediction (Breast Fibrocystic Disease) is explicitly flagged in the evidence pack as likely knowledge-graph noise — NaCl has no pharmacological activity and no causal mechanism links it to this condition; the only associated trial is a non-interventional imaging study, and all literature is basic cyst-fluid biochemistry rather than treatment evidence. This is insufficient to support any further repurposing action for this indication.

**To proceed, the following is needed:**
- Resolve blocking data gap **DG001**: obtain TFDA/HSA label warnings and contraindications (source: regulatory agency label PDF)
- Resolve high-priority data gap **DG002**: query DrugBank API for formal mechanism-of-action data to support or refute mechanistic plausibility
- If pursuing repurposing at all, redirect evaluation toward the more evidence-supported candidates in this pack — **vulvovaginitis** and **vulvitis** (L3, "Research Question" stage) — which have at least one directly relevant comparative study (PMID 22301569) on saline irrigation as an antibiotic adjunct
- Confirm Singapore market/import registration pathway, since NaCl currently has zero licenses on file
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

